Detalhe da pesquisa
1.
Expression of free fatty acid receptor 2 in normal and neoplastic tissues.
Exp Mol Pathol
; 137: 104902, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788249
2.
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.
Lancet Oncol
; 24(2): 187-194, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640790
3.
Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues.
Int J Mol Sci
; 24(4)2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835377
4.
Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.
BMC Cancer
; 22(1): 740, 2022 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35799158
5.
Clinical Features and Prognosis of Patients with Carcinoid Syndrome and Carcinoid Heart Disease: A Retrospective Multicentric Study of 276 Patients.
Neuroendocrinology
; 112(6): 547-554, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348326
6.
Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study.
Int J Mol Sci
; 23(21)2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362289
7.
Assessment of G Protein-Coupled Oestrogen Receptor Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody.
Int J Mol Sci
; 23(9)2022 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35563581
8.
Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine Neoplasms.
Ann Surg
; 274(1): e45-e53, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33030849
9.
A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms.
Int J Med Sci
; 18(10): 2166-2175, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33859524
10.
Immunohistochemical Evaluation of Adaptor Protein FAM159B Expression in Normal and Neoplastic Human Tissues.
Int J Mol Sci
; 22(22)2021 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830137
11.
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Ann Surg Oncol
; 27(5): 1348-1355, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31720931
12.
Comprehensive Assessment of GPR68 Expression in Normal and Neoplastic Human Tissues Using a Novel Rabbit Monoclonal Antibody.
Int J Mol Sci
; 20(21)2019 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31652823
13.
Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors.
Neuroendocrinology
; 107(1): 1-23, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28910819
14.
Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.
BMC Cancer
; 17(1): 896, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29282035
15.
Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains.
Neuroendocrinology
; 104(3): 302-312, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27222126
16.
Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape.
Curr Oncol Rep
; 18(5): 28, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26984415
17.
Results of Contemporary Valve Surgery in Patients with Carcinoid Heart Disease.
J Heart Valve Dis
; 25(3): 356-363, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27989047
18.
Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms.
Histopathology
; 67(3): 368-77, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25641082
19.
High uptake of (68)Ga-DOTATOC in spleen as compared to splenosis: measurement by PET/CT.
Recent Results Cancer Res
; 194: 373-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22918769
20.
Intraoperative somatostatin receptor detection after peptide receptor radionuclide therapy with (177)Lu- and (90)Y-DOTATOC (tandem PRRNT) in a patient with a metastatic neuroendocrine tumor.
Recent Results Cancer Res
; 194: 487-96, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22918778